Published in

American Association for the Advancement of Science, Science Advances, 34(7), 2021

DOI: 10.1126/sciadv.abg4081

Links

Tools

Export citation

Search in Google Scholar

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection

Journal article published in 2021 by Nader Yatim ORCID, Jeremy Boussier ORCID, Pauline Tetu, Nikaïa Smith ORCID, Timothée Bruel ORCID, Bruno Charbit ORCID, Laura Barnabei, Aurélien Corneau, Laetitia Da Meda ORCID, Clara Allayous ORCID, Barouyr Baroudjian, Majdi Jebali, Florian Herms ORCID, Ludivine Grzelak ORCID, Isabelle Staropoli and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Immune checkpoint inhibitors for melanoma improve adaptive T cell immunity during COVID-19 without exacerbating inflammation.